Indegene Ltd
NSE: INDGN BSE: 544172
₹513.60
(0.43%)
Sun, 24 May 2026, 05:01 pm
Market Cap123.18B
PE Ratio30.85
Dividend0.39
Health Technology
Pharmaceuticals: Major
24.5KIndegene Income Statement
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total revenue | 6.43B | 9.66B | 16.65B | 23.06B | 25.90B | 28.39B |
| Gross profit | 2.49B | 4.01B | 6.10B | 5.81B | 6.94B | 7.72B |
| Operating expenses (excl. COGS) | -1.24B | -1.95B | -3.54B | -2.42B | -2.56B | -3.15B |
| Selling/general/admin expenses, total | -1.24B | -1.94B | -3.52B | -2.39B | -2.57B | -3.04B |
| Research & development | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -1.24B | -1.94B | -3.52B | -2.39B | -2.57B | -3.04B |
| Other operating expenses, total | 760.00K | -6.77M | -21.60M | -24.10M | 9.00M | -106.00M |
| Operating income | 1.25B | 2.06B | 2.56B | 3.39B | 4.38B | 4.57B |
| Non-operating income, total | -498.45M | 254.78M | -290.68M | 238.02M | 205.00M | 820.00M |
| Interest expense, net of interest capitalized | -88.35M | -69.57M | -59.63M | -313.32M | -494.00M | -220.00M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 26.50M | 212.07M | 237.94M | 551.34M | 615.00M | 878.00M |
| Non-operating interest income | 9.08M | 8.85M | 8.03M | 103.05M | 296.00M | 285.00M |
| Miscellaneous non-operating expense | 17.42M | 203.22M | 229.91M | 448.29M | 319.00M | 593.00M |
| Unusual income/expense | -436.60M | 112.28M | -468.99M | 0 | 84.00M | 162.00M |
| Pretax income | 752.72M | 2.32B | 2.26B | 3.63B | 4.59B | 5.39B |
| Taxes | -261.16M | -457.80M | -636.78M | -969.48M | -1.22B | -1.33B |
| Non-controlling/minority interest | 61.24M | -80.00K | 19.44M | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 558.08M | 1.86B | 1.65B | 2.66B | 3.37B | 4.07B |
| Net income | -62.99M | 1.49B | 1.65B | 2.66B | 3.37B | 4.07B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -62.99M | 1.49B | 1.65B | 2.66B | 3.37B | 4.07B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - |
| EBITDA | 1.44B | 2.32B | 2.89B | 3.99B | 5.14B | 5.38B |
| EBIT | 1.25B | 2.06B | 2.56B | 3.39B | 4.38B | 4.57B |
| Total operating expenses | -5.18B | -7.60B | -14.09B | -19.67B | -21.52B | -23.82B |
| Prepaid expenses | 123.70M | 255.32M | 389.31M | 551.77M | 868.00M | 604.00M |
| Deferred income, current | 400.67M | 563.92M | 1.87B | 1.09B | 1.32B | 1.99B |
| Capital and operating lease obligations | 194.58M | 134.31M | 329.32M | 852.01M | 652.00M | 724.00M |
| Operating lease liabilities | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | — | — |
| Deferred income, non-current | — | — | — | — | — | — |
| Minority interest | 890.82M | 85.75M | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Asset Management Companies
Popular Stocks
Indian Indices
Sector Wise Stocks
IPO
Share Market
Best MF Schemes
Platforms
Resources
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800